Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryvyl (RVYL) Gains from Sales and Divestitures (2021 - 2025)

Ryvyl (RVYL) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $323818.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 161.93% to $323818.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $323818.0, a 161.93% increase, with the full-year FY2024 number at $214913.0, up 8.49% from a year prior.
  • Gains from Sales and Divestitures was $323818.0 for Q3 2025 at Ryvyl, down from $471747.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $563218.0 in Q4 2022 to a low of $11017.0 in Q1 2025.
  • A 5-year average of $202994.9 and a median of $160858.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 781.78% in 2023, then plummeted 95.02% in 2024.
  • Ryvyl's Gains from Sales and Divestitures stood at $359226.0 in 2021, then surged by 56.79% to $563218.0 in 2022, then tumbled by 64.83% to $198090.0 in 2023, then increased by 8.49% to $214913.0 in 2024, then skyrocketed by 50.67% to $323818.0 in 2025.
  • Per Business Quant, the three most recent readings for RVYL's Gains from Sales and Divestitures are $323818.0 (Q3 2025), $471747.0 (Q2 2025), and $11017.0 (Q1 2025).